Carlumab (Anti-CCL2 / MCP1)
Carlumab (Anti-CCL2 / MCP1) (A2573-GRP)
Products
Description
Carlumab (Anti-CCL2 / MCP1) is a humanised monoclonal antibody targeting CCL2 with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer. MW:145.5 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2573 |
| Target | Immunology & Inflammation related |